Aquestive Therapeutics, Inc. (AQST) Social Stream



Aquestive Therapeutics, Inc. (AQST): $2.68

0.05 (-1.83%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

AQUESTIVE THERAPEUTICS INC (AQST) Price Targets From Analysts

Use the tables below to see what analysts covering AQUESTIVE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 2 $28 $7 $16.333 $2.34 597.99%
2021-12-23 2 $26 $7 $15.666 $2.34 569.49%
2022-03-10 2 $14 $7 $9.666 $2.34 313.08%
2022-05-04 2 $14 $8 $11 $2.34 370.09%
2022-06-16 2 $8 $8 $8 $2.34 241.88%
2022-07-11 2 $8 $5 $6.5 $2.34 177.78%
2022-08-04 2 $5 $4 $4.5 $2.34 92.31%
2022-08-15 2 $6 $4 $5 $2.34 113.68%
2022-08-30 2 $10 $4 $6.666 $2.34 184.87%
2022-09-06 3 $10 $4 $6.333 $2.34 170.64%
2022-09-28 3 $10 $4 $6.875 $2.34 193.8%
2022-11-02 3 $10 $4 $7.125 $2.34 204.49%
2023-01-03 3 $9.5 $4 $6.375 $2.34 172.44%
2023-02-27 3 $9.5 $3 $6.125 $2.34 161.75%
2023-05-11 3 $9.5 $4 $6.375 $2.34 172.44%
2023-06-30 4 $10 $4 $6.5 $2.34 177.78%
2023-08-09 4 $10 $3 $6.6 $2.34 182.05%
2023-11-08 4 $10 $4 $6.8 $2.34 190.6%
2023-12-06 4 $10 $4 $7 $2.34 199.15%

The Trend in the Analyst Price Target


Over the past 44 weeks, AQST's average price target has gone up $0.88.

Over the past 44 weeks, AQST's average upside potential has been 325.72%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-11 3 9.5 4 6.375 2.49 156.02%
2023-05-31 3 10.0 4 6.500 2.31 181.39%
2023-06-05 3 10.0 4 6.500 2.16 200.93%
2023-06-30 3 10.0 4 6.800 1.65 312.12%
2023-06-30 4 10.0 4 6.500 1.65 293.94%

AQST Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


AQST's average broker recommendation rating improved by 0 over the prior 52 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AQST as an investment opportunity.

  • In the context of all US stocks, AQUESTIVE THERAPEUTICS INC's number of analysts covering the stock is greater than 123.19% of them.
  • AQST has a greater average analyst price target than 152.28% of all US stocks.
  • AQST has a greater upside potential (average analyst target price relative to current price) than 1659.58% of all US stocks.
  • AQST has a lower variance in analysts' estimates than -1242.8% of stocks in the small market cap category.

Stocks similar to AQUESTIVE THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are XERS, KNSA, and EOLS.

Is AQST a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!